Vision and ophthalmology stocks
Heavily traded in Vision and ophthalmology
Turnover over $10M/day22 of about 50 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Oct 30, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| 7741.THOYA Corporation | $30.47B | +9.72% | Reports Oct 30, 2026 |
| GKOSGlaukos Corporation | $185.59M | +214.54% | — |
| COOThe Cooper Companies, Inc. | $195.88M | −13.28% | — |
| KODKodiak Sciences Inc. | $82.61M | +430.38% | Reports Nov 12, 2026 |
| BLTEBelite Bio, Inc | $24.92M | +53.35% | Reports Nov 9, 2026 |
| 4536.TSanten Pharmaceutical Co., Ltd. | $2.06B | +18.55% | Reports Nov 5, 2026 |
| TARSTarsus Pharmaceuticals, Inc. | $49.46M | +9.89% | Reports Nov 4, 2026 |
| WRBYWarby Parker Inc. | $68.96M | +22.64% | Reports Nov 5, 2026 |
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
50 companies, largest market value first.
Data as of Oct 30, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 7741.T | HOYA Corporation | $55.46B | Large cap | +9.72% |
| GKOS | Glaukos Corporation | $14.30B | Large cap | +214.54% |
| COO | The Cooper Companies, Inc. | $11.47B | Large cap | −13.28% |
| C1OO34.SA | The Cooper Companies, Inc. | $11.44B | Large cap | −15.57% |
| BLCO.TO | Bausch + Lomb Corporation | $7.34B | Mid cap | +32.67% |
| KOD | Kodiak Sciences Inc. | $6.31B | Mid cap | +430.38% |
| BLTE | Belite Bio, Inc | $6.05B | Mid cap | +53.35% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.60B | Mid cap | +18.55% |
| A2LC34.SA | Alcon Inc. | $3.44B | Mid cap | −2.30% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.37B | Mid cap | +9.89% |
| BHC.TO | Bausch Health Companies Inc. | $3.32B | Mid cap | +50.97% |
| WRBY | Warby Parker Inc. | $3.04B | Mid cap | +22.64% |
| OCUL | Ocular Therapeutix, Inc. | $1.61B | Small cap | −36.32% |
| EYE | National Vision Holdings, Inc. | $1.32B | Small cap | −38.42% |
| STAA | STAAR Surgical Company | $1.27B | Small cap | −5.08% |
| SGP | SpyGlass Pharma, Inc. | $1.09B | Small cap | +23.14% |
| 7780.T | Menicon Co., Ltd. | $891.65M | Small cap | +53.65% |
| 3046.T | JINS HOLDINGS Inc. | $878.53M | Small cap | −21.98% |
| SFL.MI | Safilo Group S.p.A. | $803.08M | Small cap | +6.00% |
| SGHT | Sight Sciences, Inc. | $527.19M | Small cap | +89.88% |
| SRZN | Surrozen, Inc. | $515.41M | Small cap | +116.78% |
| OCS | Oculis Holding AG | $507.49M | Small cap | −61.76% |
| KITS.TO | Kits Eyecare Ltd. | $432.24M | Small cap | +28.28% |
| 5889.T | Japan Eyewear Holdings Co., Ltd. | $311.15M | Small cap | +5.62% |
| 262A.T | Intermestic Inc. | $309.67M | Small cap | −26.66% |
| RXST | RxSight, Inc. | $203.81M | Small cap | −40.09% |
| 7743.T | SEED Co.,Ltd. | $150.98M | Small cap | +41.85% |
| OTLK | Outlook Therapeutics, Inc. | $132.65M | Small cap | −61.45% |
| LENZ | LENZ Therapeutics, Inc. | $109.66M | Small cap | −88.61% |
| OKYO | OKYO Pharma Limited | $78.19M | Micro cap | −44.85% |
| LNSR | LENSAR, Inc. | $73.35M | Micro cap | −49.83% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | $66.08M | Micro cap | +5.19% |
| 4596.T | Kubota Pharmaceutical Holdings Co., Ltd. | $59.69M | Micro cap | 0.00% |
| KLRS | Kalaris Therapeutics, Inc. | $50.70M | Micro cap | −56.26% |
| 4890.T | Tsubota Laboratory Incorporated | $40.93M | Micro cap | −21.67% |
| ALDX | Aldeyra Therapeutics, Inc. | $39.76M | Micro cap | −86.96% |
| 9854.T | Aigan Co.,Ltd. | $34.54M | Micro cap | +68.24% |
| EYPT | EyePoint, Inc. | $32.54M | Micro cap | −96.76% |
| ALCOX.PA | Nicox S.A. | $32.18M | Micro cap | −13.79% |
| EYE.AX | Nova Eye Medical Limited | $30.08M | Micro cap | −6.25% |
| 4576.T | D. Western Therapeutics Institute, Inc. | $22.25M | Micro cap | −41.51% |
| 7782.T | Sincere Co., LTD. | $21.06M | Micro cap | −3.67% |
| IRIX | IRIDEX Corporation | $12.72M | Micro cap | −29.70% |
| KPRX | Kiora Pharmaceuticals, Inc. | $7.79M | Micro cap | −30.43% |
| 0GWJ.L | Clínica Baviera, S.A. | — | — | +30.79% |
| AFX.DE | Carl Zeiss Meditec AG | — | Mid cap | −28.88% |
| ALC.SW | Alcon Inc. | — | — | −8.50% |
| EL.PA | EssilorLuxottica Société anonyme | — | Large cap | −50.42% |
| FIE.DE | Fielmann Group AG | — | Mid cap | −23.57% |
| MRX.DE | Mister Spex SE | — | — | −27.78% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 50 companies grouped under the Vision and ophthalmology theme. The median market value in the group is $469.86M. Among the 28 with a price from the latest session, the median move over the past trading day is +1.56%. 37% of the 49 with a 200-day average trade above it. Price change over the past year runs from −56.8% to +55.1% across the middle 80 percent of the group, with a median of −7.4%.